{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T13:12:38Z","timestamp":1699794758917},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1975,1,1]],"date-time":"1975-01-01T00:00:00Z","timestamp":157766400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacologia"],"published-print":{"date-parts":[[1975]]},"DOI":"10.1007\/bf00421271","type":"journal-article","created":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:30:28Z","timestamp":1100046628000},"page":"293-297","source":"Crossref","is-referenced-by-count":16,"title":["Dopaminergic drugs antagonize the psychotomimetic effects of partial-agonist analgesics"],"prefix":"10.1007","volume":"42","author":[{"given":"W. R.","family":"Buckett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. S.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/B978-0-08-017922-3.50120-9","volume-title":"Frontiers in catecholamine research","author":"G. K. Aghajanian","year":"1973","unstructured":"Aghajanian, G. K., Bunney, B. S.: Central dopaminergic neurons: neurophysiological identification and responses to drug. In: Frontiers in catecholamine research, E. Usdin and S. Snyder, eds., pp. 643?648. Elmford-New York: Pergamon Press 1973"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.2042-7158.1967.tb09604.x","volume":"19","author":"N.-E. And\u00e9n","year":"1967","unstructured":"And\u00e9n, N.-E., Rubenson, A., Fuxe, K., H\u00f6kfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627?629 (1967)","journal-title":"J. Pharm. Pharmacol."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00421425","volume":"30","author":"B. Angrist","year":"1973","unstructured":"Angrist, B., Gershon, S.: Behavioural profile of a potent new psychotoxic compound. Psychopharmacologia (Berl.) 30, 109?116 (1973)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR4","first-page":"283","volume":"204","author":"I. H. Ayhan","year":"1973","unstructured":"Ayhan, I. H., Randrup, A.: Inhibitory effects of amphetamine, l-Dopa and apomorphine on morphine-induced behavioural excitation of rats. Arch. int. Pharmacodyn. 204, 283?292 (1973)","journal-title":"Arch. int. Pharmacodyn."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/B978-0-08-017922-3.50127-1","volume-title":"Frontiers in catecholamine research","author":"C. L. E. Broekkamp","year":"1973","unstructured":"Broekkamp, C. L. E., Pijnenburg, A. J. J., van Rossum, J. M.: Dopaminergic transmission in relation to mechanisms underlying stereotyped behaviour. In: Frontiers in catecholamine research, E. Usdin and S. Snyder, eds., pp. 675?676. Elmford-New York: Pergamon Press 1973"},{"issue":"Suppl. 2","key":"CR6","first-page":"12","volume":"5","author":"W. R. Buckett","year":"1974","unstructured":"Buckett, W. R., Shaw, J. S.: Mechanism for the production of psychotomimetic side-effects by partial-agonist analgesic agents. J. Pharmacol. (Paris) 5, Suppl. 2, 12 (1974)","journal-title":"J. Pharmacol. (Paris)"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/BF00501138","volume":"283","author":"A. Carlsson","year":"1974","unstructured":"Carlsson, A., Engel, J., Str\u00f6mbom, U., Svensson, T. H., Waldeck, B.: Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg's Arch. Pharmacol. 283, 117?128 (1974)","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR8","first-page":"128","volume-title":"Agonist and antagonist actions of narcotic analgesic drugs","author":"H. O. J. Collier","year":"1972","unstructured":"Collier, H. O. J., Schneider, C.: Some agonist and antagonist properties of morphine antagonists in rodents. In: Agonist and antagonist actions of narcotic analgesic drugs, H. W. Kosterlitz, H. O. J. Collier, and J. E. Villareal, eds., pp. 128?135. London: Macmillan 1972"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1476-5381.1971.tb09935.x","volume":"41","author":"E. Costa","year":"1971","unstructured":"Costa, E., Gropetti, A., Revuelta, A.: Action of fenfluramine on monoamine stores of rat tissues. Brit. J. Pharmacol. 41, 57?64 (1971)","journal-title":"Brit. J. Pharmacol."},{"key":"CR10","first-page":"266","volume-title":"Agonist and antagonist actions of narcotic analgesic drugs","author":"M. Fink","year":"1972","unstructured":"Fink, M., Freedman, A. M., Resnick, R., Zaks, A.: Clinical status of the narcotic antagonists in opiate dependence. In: Agonist and antagonist actions of narcotic analgesic drugs, H. W. Kosterlitz, H. O. J. Collier, and J. E. Villareal, eds., pp. 266?276. London: Macmillan 1972"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00402763","volume":"18","author":"C. A. Haertzen","year":"1970","unstructured":"Haertzen, C. A.: Subjective effects of narcotic antagonists cyclazocine and nalorphine on the Addiction Research Centre Inventory (ARCI). Psychopharmacologia (Berl.) 18, 366?377 (1970)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR12","first-page":"380","volume":"187","author":"S. G. Holtzman","year":"1973","unstructured":"Holtzman, S. G., Jewett, R. E.: Stimulation of behaviour in the rat by cyclazocine: Effects of naloxone. J. Pharmacol. exp. Ther. 187, 380?390 (1973)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-08-017922-3.50073-3","volume-title":"Frontiers in catecholamine research","author":"L. L. Iversen","year":"1973","unstructured":"Iversen, L. L.: Neuronal and extraneuronal catecholamine uptake mechanisms. In: Frontiers in catecholamine research, E. Usdin and S. Snyder, eds., pp. 403?408. Elmford-New York: Pergamon Press 1973"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/cpt196892215","volume":"9","author":"D. R. Jasinski","year":"1968","unstructured":"Jasinski, D. R., Martin, W. R., Sapira, J. D.: Antagonism of the subjective, behavioural, pupillary and respiratory depressant effects of cyclazocine by naloxone. Clin. Pharmacol. Ther. 9, 215?222 (1968)","journal-title":"Clin. Pharmacol. Ther."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0014-2999(74)90072-7","volume":"26","author":"K. Kuschinsky","year":"1974","unstructured":"Kuschinsky, K., Hornykiewicz, O.: Effects of morphine on striatal dopamine metabolism: possible mechanism of its opposite effect on locomotor activity in rats and mice. Europ. J. Pharmacol. 26, 41?50 (1974)","journal-title":"Europ. J. Pharmacol."},{"key":"CR16","first-page":"356","volume":"112","author":"L. Lasagna","year":"1954","unstructured":"Lasagna, L., Beecher, H. K.: The analgesic effectiveness of nalorphine and nalorphine-morphine combinations in man. J. Pharmacol. exp. Ther. 112, 356?363 (1954)","journal-title":"J. Pharmacol. exp. Ther."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1126\/science.177.4045.249","volume":"177","author":"T. H. Maugh","year":"1972","unstructured":"Maugh, T. H.: Narcotic antagonists: the search accelerates. Science 177, 249?250 (1972)","journal-title":"Science"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-2999(70)90007-5","volume":"11","author":"T. Persson","year":"1970","unstructured":"Persson, T., Waldeck, B.: Further studies on the possible interaction between dopamine and noradrenaline containing neurones in the brain. Europ. J. Pharmacol. 11, 315?320 (1970)","journal-title":"Europ. J. Pharmacol."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/220586a0","volume":"220","author":"C. L. Schneider","year":"1968","unstructured":"Schneider, C. L.: Behavioural effects of some morphine antagonists and hallucinogens in the rat. Nature (Lond.) 220, 586?587 (1968)","journal-title":"Nature (Lond.)"},{"key":"CR20","first-page":"205","volume":"I","author":"A. J. J. Wood","year":"1974","unstructured":"Wood, A. J. J., Moir, D. C., Campbell, C., Davidson, J. F., Gallon, S. C., Henney, E., McAllion, S.: Central nervous system effects of pentazocine. Brit. med. J. 1974I, 205?207","journal-title":"Brit. med. J."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00421916","volume":"26","author":"S. R. Wray","year":"1972","unstructured":"Wray, S. R.: A correlative evaluation of cyclazocine, L.S.D. and naloxone on continuous discriminated avoidance in rats. Psychopharmacologia (Berl.) 26, 29?43 (1972)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00422872","volume":"30","author":"S. R. Wray","year":"1973","unstructured":"Wray, S. R.: Interaction of stress and psychotomimetic drug action: Possible implication for psychosis. Psychopharmacologia (Berl.) 30, 263?268 (1973)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF00403864","volume":"21","author":"S. R. Wray","year":"1971","unstructured":"Wray, S. R., Cowan, A.: The behavioural effects of levallorphan, cyprenorphine (M285) and amphetamine on repeated Y-maze performance in rats. Psychopharmacologia (Berl.) 21, 257?267 (1971)","journal-title":"Psychopharmacologia (Berl.)"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/BF00401788","volume":"22","author":"S. R. Wray","year":"1971","unstructured":"Wray, S. R., Cowan, A. L.: The effects of naloxone, chlorpromazine and haloperidol pretreatment on levallorphan-induced disruption of rats' operant behaviour. Psychopharmacologia (Berl.) 22, 261?270 (1971a)","journal-title":"Psychopharmacologia (Berl.)"}],"container-title":["Psychopharmacologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00421271\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00421271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T19:58:06Z","timestamp":1554321486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00421271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1975]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1975]]}},"alternative-id":["BF00421271"],"URL":"https:\/\/doi.org\/10.1007\/bf00421271","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1975]]}}}